| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $101K | — | +57.8% |
| Cost of Revenue | $201K | — | +109.4% |
| Gross Profit | -$100K | — | -212.5% |
| R&D Expense | $3.8M | — | +7.9% |
| SG&A Expense | $4.2M | — | +44.3% |
| Operating Income | -$9.0M | — | -32.8% |
| Pre-tax Income | -$8.3M | — | -4.1% |
| Income Tax | $2K | — | +0.0% |
| Net Income | -$8.3M | — | -4.1% |
| EPS (Basic) | -$0.18 | — | +60.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $45.2M | +4.2% | +757.5% |
| Accounts Receivable | $96K | +24.7% | +1500.0% |
| Inventory | $963K | -5.1% | +853.5% |
| Current Assets | $79.7M | -11.1% | +195.6% |
| Total Assets | $82.1M | -9.7% | +184.9% |
| Current Liabilities | $6.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.6M | — | -9.6% |
| Capital Expenditures | $187K | — | +3016.7% |
| Investing Cash Flow | $10.7M | — | +224.9% |
| Financing Cash Flow | -$352K | — | -103.1% |
| Free Cash Flow | -$8.7M | — | -11.9% |
| -42.6% |
| Total Liabilities | $7.8M | -18.0% | -33.6% |
| Stockholders' Equity | $74.2M | -8.8% | +336.6% |